Live
Breast Cancer Oncotype Testing
£490,050
Lincolnshire Partnership NHS Foundation TrustExact Sciences UK, Ltd.
goods
Contract Details
- Tender Value
- £490,050
- Stage
- Live
- Published
- Awarded
Timeline
Start
Awarded
Disclosed
End
Description
Provision of Prognostic Genetic Testing for Breast Cancer Patients - to Improve availability of Oncotype DX to Breast cancer patients, reducing the need for post-operative chemotherapy. Additional information: Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831,
Related Contracts
From This Buyer
- Apprenticeships - Data Engineers & Data Analysts
£83,000 ·
- Nursing Agency Provision
£999,000 ·
- Project Manager for PHC Construction Phase
£50,000 ·
- EV Charger Installation
£25,000 ·
From This Supplier
Ref: 0db1b1d6-da40-4244-9eb1-58948b0ce6ec-744894 · Sourced from Contracts Finder
View source notice